Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
498 participants
INTERVENTIONAL
2018-05-17
2020-05-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dexamethasone Before Elective Cesarean Section at Term in Reducing Neonatal Respiratory Distress Syndrome
NCT04816097
Dexamethasone in Prevention of Respiratory Morbidity in Elective Caesarean Section in Term Fetus
NCT01772381
Postoperative Dexamethasone on Post-Cesarean Pain
NCT04067609
Dexamethasone for Post-operative Pain After Cesarean Delivery Under Neuraxial Anesthesia.
NCT07257406
Effect of Intravenous Dexamethasone Before Spinal Anesthesia on Post-cesarean Section Pain
NCT03122756
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Interestingly, recent evidence indicates that apart from the traditional mechanical concept of vaginal squeeze, molecular mechanisms (predominantly lung epithelial sodium channels promote alveolar uid drainage, and these channels are under active in fetuses unexposed to the process of labor. Glucocorticoid appears to increase the number and the function of thyroid hormones, providing a rational for their exogenous administration in cases of elective caesarean delivery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dexamethasone
Dexamethasone 6mg, IM, 48 hours before cesarean section
Dexamethasone
Dexamethasone 6mg, IM, 48 hours before cesarean section
Placebo
Placebo 6mg, IM, 48 hours before cesarean section
Placebo
Placebo 6mg, IM, 48 hours before cesarean section
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dexamethasone
Dexamethasone 6mg, IM, 48 hours before cesarean section
Placebo
Placebo 6mg, IM, 48 hours before cesarean section
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Singleton pregnancy
* Gestational age (38-40 years)
Exclusion Criteria
* Sever oligohydramnios
* Premature rupture of membranes
* Women who receive steroids during pregnancy
18 Years
35 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohammed Mostafa Haroun
Principle investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmed Fayek, Professor
Role: STUDY_CHAIR
Assiut University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assiut university
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Barber EL, Lundsberg LS, Belanger K, Pettker CM, Funai EF, Illuzzi JL. Indications contributing to the increasing cesarean delivery rate. Obstet Gynecol. 2011 Jul;118(1):29-38. doi: 10.1097/AOG.0b013e31821e5f65.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ACESC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.